{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:52:00Z","timestamp":1761292320358},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T00:00:00Z","timestamp":1144713600000},"content-version":"vor","delay-in-days":3053,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold> In response to topical application of irritants, increased concentrations of prostaglandin E<jats:sub>2<\/jats:sub> (PGE<jats:sub>2<\/jats:sub>) are found in human skin exudate and in cultured dermal fibroblasts. In this study, PGE<jats:sub>2<\/jats:sub> generated in response to transdermal delivery of irritant drug compounds was monitored in hairless guinea pig (HOP) by a non\u2010invasive method, reverse iontophoresis. Reverse iontophoresis is the movement of molecules from the skin under the influence of an applied electric field. Irritant drug compounds were applied with iontophoresis (electrotransport), and reverse iontophoresis of PGE<jats:sub>2<\/jats:sub> from skin was monitored by radioimmunoassay (RIA) after extraction from the delivery system. Chlorpromazine was used as a model drug irritant. When chlorpromazine and saline were applied over a range of current densities from 0 to 200 \u03bcA\/cm<jats:sup>2<\/jats:sup>, visual scores of erythema and edema yielded a correlation with measured skin efflux of PGE<jats:sub>2<\/jats:sub> (<jats:italic>r<\/jats:italic>=0.86). Delivery of chlorpromazine resulted in greater efflux of PGE<jats:sub>2<\/jats:sub> than delivery of non\u2010irritant saline controls under the same delivery conditions. Five drug compounds, chloroquine, promazine, chlorpromazine, tetracaine, metoclopramide, and saline were applied to hairless guinea pig skin. The 6 agents were similarly rank ordered by visual erythema\/edema scores and by PGE<jats:sub>2<\/jats:sub> efflux, indicating that the quantity of PGE<jats:sub>2<\/jats:sub> effluxed reflects the intensity of skin irritation. In contrast, vasoconstriction or vasodilation produced by the local delivery of vasoactive agents did not correlate with PGE<jats:sub>2<\/jats:sub> skin efflux, indicating that this measurement is specific for an inflammatory response. In summary, PGE<jats:sub>2<\/jats:sub> generated in response to transdermally applied drug irritants can be monitored non\u2010invasively <jats:italic>in vivo<\/jats:italic> by reverse iontophoresis.<\/jats:p>","DOI":"10.1111\/j.1600-0625.1997.tb00176.x","type":"journal-article","created":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T17:19:43Z","timestamp":1144775983000},"page":"298-302","source":"Crossref","is-referenced-by-count":21,"title":["Reverse iontophoresis: monitoring prostaglandin E<sub>2<\/sub> associated with cutaneous inflammation <i>in vivo<\/i>"],"prefix":"10.1111","volume":"6","author":[{"given":"Nancy K.","family":"Mize","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Daddona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,11]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"377","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize J H.","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb04012.x"},{"issue":"2","key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/oxfordjournals.bmb.a072190","article-title":"Inflammatory mediators in the skin","volume":"43","author":"Camp R D R","year":"1987","journal-title":"Br Med Bull"},{"key":"e_1_2_1_5_2","first-page":"S33","article-title":"Prostaglandins, leukotrienes, phospholipase. platelet activating factor, and cytokines: an integrated approach to inflammation of human skin","volume":"250","author":"Greaves M W.","year":"1988","journal-title":"Arch Dermatol Res"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018926215306"},{"key":"e_1_2_1_7_2","first-page":"13","article-title":"Iontophoretic and noninvasive glucose monitoring","volume":"21","author":"Rao G.","year":"1994","journal-title":"Proc Intern Symp Control Rel Bioact Mater"},{"key":"e_1_2_1_8_2","unstructured":"CormierM.LedgerP W JohnsonJ.PhippsJ B.ChaoS.Reduction of skin irritation and resistance during electrotransport U.S. patent 5 624 415. April 29 1997."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(93)80048-6"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248520"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)80314-7"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431067"},{"key":"e_1_2_1_13_2","first-page":"167","article-title":"Skin reflectance spectrophotometry","volume":"4","author":"Bjerrring P","year":"1987","journal-title":"Photodermatology"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2340\/00015555515054","article-title":"Continuous skin perfusion in vivo as a method for study of pharmacological agents in human skin","volume":"51","author":"Greaves M W","year":"1971","journal-title":"Acta Derm Venercol (Stockh)"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb01788.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91935-3"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12535038"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/270530a0"},{"key":"e_1_2_1_19_2","first-page":"270","article-title":"Prostaglandins in human burn blister fluid","volume":"84","author":"Arturson G.","journal-title":"Acta Physiol Scand"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.110.4.556"},{"key":"e_1_2_1_21_2","first-page":"615","article-title":"Prostaglandin activity in sustained inflammation of human skin before and after aspirin","volume":"52","author":"Plummer N A","year":"1977","journal-title":"Clin Sci Mol Med"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.1997.tb00176.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.1997.tb00176.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T18:50:51Z","timestamp":1698432651000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.1997.tb00176.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1111\/j.1600-0625.1997.tb00176.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.1997.tb00176.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}